Your Three-Month GLP-1 Check-In: What to Review With Your Clinician

A follow-up appointment is a chance to step back from day-to-day symptoms and ask whether the treatment plan still fits. We've used three months as an example here, but it isn't a universal clinical schedule: some people are reviewed earlier or later depending on the medicine, the reason for treatment, where they are in dose escalation, their symptoms and local guidance. Follow the schedule your care team sets.

Review the goal you agreed on

Start with why you began treatment. It might be blood-sugar control, weight management, or another health outcome your specific product is approved for. Ask which measures matter in your case and how they'll be assessed. Weight is useful for some goals, but it's not the only measure, and a single weigh-in can't capture the full picture—tracking progress beyond the scale can help here.

Bring symptoms and routine problems into the room

Summarize side effects and how they affected daily life, any trouble eating or drinking, missed doses, access interruptions and changes to other medicines. A short, factual side-effect log makes this much easier. Mention cost or insurance problems without embarrassment. In a 2025 US real-world study of 853 people prescribed GLP-1 medicines for obesity, 35.6% stopped within two years; the most common reasons were losing follow-up with their prescriber, side effects and insurance coverage ending. Practical barriers belong in care planning.

Review the medication plan

Confirm the exact product, the dose schedule as prescribed, how to store it, what to do about missed doses and which symptoms mean you should get in touch. Don't increase your dose on your own because you expected faster results. Ask what timeline will be used to judge whether treatment is working and when your next follow-up should be.

Questions worth asking

• What is going well, and what isn't meeting the goal yet?
• Do any of my symptoms need assessment or extra support?
• Are my other medicines or health conditions relevant?
• How should we handle cost, supply or travel disruptions?
• What is our plan if benefits are limited or side effects continue?

If you're wondering what a clinician might look at when progress is slower than hoped, see what doctors review when GLP-1 treatment isn't helping enough.

Leave with a clear next step

Ask for important instructions in writing, especially if the plan changes. Keeping your timeline and symptom notes in one place, whether on paper or in an app like GLPily, can help you explain patterns clearly—but decisions about adjusting treatment stay with your clinician.

A useful review isn't a pass/fail exam. It's a chance to make care safer, more realistic and better aligned with your health goals.